Literature DB >> 24094108

Cytosolic transmitter concentration regulates vesicle cycling at hippocampal GABAergic terminals.

Lu Wang1, Peng Tu, Laurine Bonet, Karin R Aubrey, Stéphane Supplisson.   

Abstract

Sustained synaptic transmission requires vesicle recycling and refilling with transmitter, two processes considered to proceed independently. Contrary to this assumption, we show here that depletion of cytosolic transmitter at GABAergic synapses reversibly reduces the number of recycling vesicles. Using paired recordings in hippocampal cultures, we show that repetitive activity causes two phases of reduction of the postsynaptic response. The first involves the classical depletion of the readily releasable and recycling pools, while the second reflects impairment of vesicle filling as GABA is consumed, since it can only be reversed by uptake of GABA or its precursors, glutamate or glutamine. Surprisingly, this second phase is associated with reduced quantal release, a faster depression rate and lower FM5-95 labeling, suggesting that the size of the cycling vesicular pool is regulated by cytosolic transmitter availability. Regulation of vesicular cycling may represent a general mechanism of presynaptic plasticity, matching synaptic release to transmitter supply.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24094108     DOI: 10.1016/j.neuron.2013.07.021

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  20 in total

1.  Gad1 mRNA as a reliable indicator of altered GABA release from orexigenic neurons in the hypothalamus.

Authors:  Matthew S Dicken; Alexander R Hughes; Shane T Hentges
Journal:  Eur J Neurosci       Date:  2015-10-19       Impact factor: 3.386

2.  Activity and Cytosolic Na+ Regulate Synaptic Vesicle Endocytosis.

Authors:  Yun Zhu; Dainan Li; Hai Huang
Journal:  J Neurosci       Date:  2020-06-30       Impact factor: 6.167

3.  Cytosolic Accumulation of L-Proline Disrupts GABA-Ergic Transmission through GAD Blockade.

Authors:  Gregg W Crabtree; Alan J Park; Joshua A Gordon; Joseph A Gogos
Journal:  Cell Rep       Date:  2016-10-04       Impact factor: 9.423

4.  Caloric restriction selectively reduces the GABAergic phenotype of mouse hypothalamic proopiomelanocortin neurons.

Authors:  Brooke C Jarvie; Connie M King; Alexander R Hughes; Matthew S Dicken; Christina S Dennison; Shane T Hentges
Journal:  J Physiol       Date:  2016-10-02       Impact factor: 5.182

Review 5.  Mechanisms and functions of GABA co-release.

Authors:  Nicolas X Tritsch; Adam J Granger; Bernardo L Sabatini
Journal:  Nat Rev Neurosci       Date:  2016-02-11       Impact factor: 34.870

6.  Tonotopic Specializations in Number, Size, and Reversal Potential of GABAergic Inputs Fine-Tune Temporal Coding at Avian Cochlear Nucleus.

Authors:  Mohammed Al-Yaari; Chikao Onogi; Rei Yamada; Ryota Adachi; Daiya Kondo; Hiroshi Kuba
Journal:  J Neurosci       Date:  2021-09-13       Impact factor: 6.167

7.  A local glutamate-glutamine cycle sustains synaptic excitatory transmitter release.

Authors:  Hiroaki Tani; Chris G Dulla; Zoya Farzampour; Amaro Taylor-Weiner; John R Huguenard; Richard J Reimer
Journal:  Neuron       Date:  2014-02-19       Impact factor: 17.173

8.  Shifted pallidal co-release of GABA and glutamate in habenula drives cocaine withdrawal and relapse.

Authors:  Frank J Meye; Mariano Soiza-Reilly; Tamar Smit; Marco A Diana; Martin K Schwarz; Manuel Mameli
Journal:  Nat Neurosci       Date:  2016-06-27       Impact factor: 24.884

9.  Midbrain dopamine neurons sustain inhibitory transmission using plasma membrane uptake of GABA, not synthesis.

Authors:  Nicolas X Tritsch; Won-Jong Oh; Chenghua Gu; Bernardo L Sabatini
Journal:  Elife       Date:  2014-04-24       Impact factor: 8.140

10.  A neuron-glia interaction involving GABA transaminase contributes to sleep loss in sleepless mutants.

Authors:  W-F Chen; S Maguire; M Sowcik; W Luo; K Koh; A Sehgal
Journal:  Mol Psychiatry       Date:  2014-03-18       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.